Ark Invest Buys $5M in Bullish Shares After Mixed Q1
Ark Invest bought 139,117 Bullish shares – about $5 million – across ARKK, ARKW and ARKF ETFs as Bullish stock fell 2.73% to $35.96 after mixed Q1 results.
Ark Invest purchased 139,117 shares of Bullish on Thursday across its ARK Innovation (ARKK), Next Generation Internet (ARKW) and Blockchain and Fintech Innovation (ARKF) ETFs. The stake was worth about $5 million based on the stock's closing price.
The trades were disclosed in Ark's daily trading report. The firm also bought roughly $4.4 million of Bullish shares on Monday and Tuesday across the same three ETFs.
Bullish's NYSE-listed shares closed at $35.96, down 2.73% on Thursday. The stock has declined 8.9% over the past five trading sessions and 14.2% over the past month.
Bullish released first-quarter results last week showing a net loss of $604.9 million, nearly double the loss reported a year earlier. Adjusted revenue rose to $92.8 million from $62.4 million in the same quarter a year ago.
The company announced a planned $4.2 billion acquisition of Equiniti. Tom Farley described the deal as a way to accelerate growth, adding, “Broad adoption at institutional scale requires three things: end-to-end tokenization services, a single, unified ledger and a broad base of blue-chip issuer relationships, at scale.”
Bullish went public in August 2025, pricing 30 million shares at $37 each. The company holds about 24,300 bitcoin, ranking it sixth among public corporate holders.
Ark's purchases increased its stake in Bullish as the company reported higher revenue, a larger loss and the announced acquisition.
The content on The Coinomist is for informational purposes only and should not be interpreted as financial advice. While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, or reliability of any content. Neither we accept liability for any errors or omissions in the information provided or for any financial losses incurred as a result of relying on this information. Actions based on this content are at your own risk. Always do your own research and consult a professional. See our Terms, Privacy Policy, and Disclaimers for more details.








